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INTRODUCTION 
Spontaneous abortion or miscarriage is defined as the involuntary 
termination of pregnancy before 20 weeks of gestation or below fetal 
weight of 500 g. 
Traditionally, Recurrent pregnancy loss was defined as three or 
more consecutive spontaneous miscarriages. In 1930s and 1940s, 
Malpas and Eastman suggested that the proportion to pregnancy losses 
in next pregnancy after three consecutive losses was as high as 73 - 
84%1. Incidence 1 in 300 pregnancies2. Years later, clinical studies 
demonstrated that the risk of miscarriage is actually lower than 
predicted.                    
  In the recent era, investigation and treatment is considered in 
couples with two consecutive spontaneous miscarriages, documented by 
ultrasound or histopathological examination (Leon Speroff et al).  
Evaluation is indicated when any of the following are present 
x Embryonic heart activity observed before any earlier pregnancy 
loss 
x Normal karyotype of the products of conception obtained  from 
an earlier loss  
x Female partner  over 35 years of age, Women with previous 
history of  infertility   
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 The risk of recurrent pregnancy loss in young women 
 Women who have had at least one live born infant 3 
Number of prior 
miscarriages 
% risk of miscarriage 
in next pregnancies 
0 12% 
1 24% 
2 26% 
3 32% 
4 26% 
6 53% 
 
Previous reproductive history is a significant individual predictor 
of future outcome of a pregnancy.  Women with a history of live births 
have a reduced risk of miscarriage in their subsequent pregnancy when 
compared to women whose pregnancy ended in miscarriage. 
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Women who have not had at least one live born infant 4 
Number of prior 
miscarriages 
% risk of miscarriage 
in next pregnancies 
2 24% 
3 30% 
4 40-50% 
 
ETIOLOGY OF RECURRENT  PREGNANCY  LOSS 
1) Genetic factors : 3.5 – 5 % 
2) Anatomical factors :  12 -16 % 
3) Endocrine factors : 17 – 20 % 
4) Infectious factors  : 0.5 – 5 % 
5) Immunologic factors :  20 -50 % 
6) Thrombotic factors 
7) Others: 10 % ( environmental, placental abnormalities, male 
factors, medical illness, altered uterine receptivity, exercise, 
yssynchronous fertilization ). 
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3.5-5%
12-16%
17-20%
0.5-5%
50%
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Figure 1: Etiology of Recurrent Miscarriage 
The prognosis for successful pregnancy depends both on the 
underlying cause and the number of previous losses. The chance of a 
viable birth even after four pregnancy losses is as high as 60%.  
Prognosis for a viable birth After 
One spontaneous loss 76% 
Two spontaneous loss 70% 
Three spontaneous loss 65% 
Four spontaneous loss 60% 
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          When a causative factor is identified, specific treatment can 
help in improving the prognosis for a successful pregnancy. 
Of  all the causative factors described, an average success rate of  
70-80%  is achieved after correcting the abnormalities. Only with the 
early diagnosis and treatment of the Endocrinological dysfunction a 
success rate of more than 90% is achieved. 
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AIM OF THE STUDY 
1. To evaluate the prevalence of diabetes both preconceptionally and 
antenatally in a women with previous history of  recurrent 
miscarriage. 
2. To evaluate the association of thyroid dysfunction in a women 
with history of  recurrent miscarriage. 
      3. To evaluate the prevalence of  hyperprolactinemia in recurrent 
miscarriage. 
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REVIEW OF LITERATURE 
                      EPIDEMIOLOGY OF PREGNANCY LOSS 
Early pregnancy loss is a very common traumatic event. Almost 
all chromosomally abnormal conception aborts spontaneously before 10 
weeks of gestation, and 90% of conception with a normal karyotype 
continue 5. Miscarriage may be viewed as a natural selection process for 
quality control. 
  Over all, approximately 12 – 15% of clinically recognized 
pregnancies results in spontaneous miscarriage before 20 weeks of 
gestation. Nearly about 30 - 60% of all conceptions will spontaneously 
get aborted within first 12 weeks of gestation; out of which half of the 
losses go unnoticed and this loss occurs even before a first missed 
menses. 
 
         
 
 
Figure 2: Epidemiology of Pregnancy loss 
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AGE AND MISCARRIAGE 
Maternal age acts as a risk factor for miscarriage, due to the 
formation of  chromosomally abnormal conceptions 6 
As age increases, there is increase in the incidence of mitotic 
segregation errors, rapid rise on number of aneuploid oocyte . Women 
with a demonstrated low ovarian reserve have an extremely higher rate 
of miscarriage, regardless of age 7. 
In women with history of previous losses, advancing age adds to 
the risk related to previous losses. If  both occult and recognized losses 
are considered, total pregnancy wastage in women over age 40 may 
exceed 75% 2 
PROGNOSTIC VALUE OF TRANSVAGINAL ULTRASOUND 
OBSERVATIONS 
The risk of miscarriage decreases as the duration of pregnancy 
advances. The risk of pregnancy loss falls progressively after 
appearance of gestational sac (12%), yolk sac (8%), as crown rump 
length increases, ( greater than 5mm – 7%, 6 – 10mm – 3%, more than 
10 mm – less than 1% )   
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Appearance of embryonic cardiac activity by approximately 6 
weeks is another important developmental mile stone and good 
prognostic indicator. In both normal and infertile asymptomatic young 
women, the appearance of embryonic heart activity decreases with the 
risk of pregnancy losses from 12% - 15% to 3 – 5%. 8 
GENETIC FACTORS 
           Most spontaneous miscarriages occur due to the chromosomal 
abnormalities in the embryo or fetus. Large number of abortuses have 
been cultured and karyotype suggested that approximately 50 % of all 
first trimester pregnancy losses, 30% of second trimester abortuses, and 
3 % of still births are chromosomal abnormal 9 
Chromosomal abnormalities 
90% - numerical (aneuploidy, polyploidy) 
10% - structural abnormality (translocation , inversion and 
mosaicism) 
Autosomal trisomy are the most common usually involving 
chromosome 13 – 16, 21 or 22, followed by monosomy X  
(45 X).42,44,45,21 The likelihood of euploid abortus increases with the 
number of previous miscarriages and after a previous abortion having a 
normal karyotype.  
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Parental chromosomal abnormality 
  However, in 4 -8 % of couples with recurrent pregnancy loss, one 
or other partner harbours a chromosomal abnormality that markedly 
increases the probability of a chromosomally abnormal conceptus.10 
Balanced translocation (Reciprocal, Robertsonian) are the most common 
abnormalities. 
The chance of a livebirth rate in couples with a structural 
chromosome abnormality who conceive spontaneously is higher (50–
65%) than couples who conceive after assisted reproductive methods. 
Inversions 
         Pericentric inversion 9  occurs in 1 – 1.5 % in general population, 
this is a normal variant with no importance. Paracentric inversion results 
in abortion and anomalous fetus.  
 Karyotyping data likely underestimated the prevalence of 
chromosomal abnormalities due to unrecognized maternal cell 
contamination; normal euploid cells are less likely to fail culture than 
abnormal cell lines. 11 
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     Some genetic abnormality cannot be detected using standard 
Cytogenic techniques like isolated gonadal / germ line mosaicism/single 
gene defects. 
         Analyses using newer techniques not dependent on cell culture 
(FISH – fluorescence in situ hybridization, CGH – comparative genomic 
hybridization) suggest that the true incidence of chromosomal 
abnormalities in miscarried early pregnancies is closer to 75%. 
ANATOMIC FACTORS 
CONGENITAL UTERINE MALFORMATIONS 
The prevalence of uterine anomaly in general population is 2%, 
and in patients with recurrent miscarriage accounts for about 6 – 7%.12               
Unicornuate Uterus 
Pregnancy outcomes are generally poor; approximately half of all 
recognized pregnancies fail. Since 40 % of the cases are associated with 
an ipsilateral renal agenesis. Further evaluation with intravenous 
pyelogram or renal sonogram is also indicated in the inter pregnancy 
period. Evidence suggest that most pregnancies in women with 
unicornuate uterus are best managed expectantly with cervical circlage 
12 
 
reserved for those with previous second trimester losses or evidence of 
progressive cervical shortening. 13 
Uterine Didelphys 
40 % of women with uterine didelphys end in spontaneous 
miscarriage. Unification procedures are usually unnecessary, but can 
benefit some women with numerous miscarriages or previable births. 
When surgery is performed, the recommended technique unifies the two 
fundi and leaves the two cervices intact  
Bicornuate Uterus 
         Data reveals miscarriage and overall fetal loss rates of 30% & 40% 
respectively. Surgery is generally unnecessary and best reserved for 
those with a well established history of otherwise unexplained recurrent 
pregnancy loss or previable . The incidence of cervical incompetence is 
highest in this group and evidence suggests that cervical circlage 
improves fetal survival rates. 14 
Septate Uterus 
The  most common uterine developmental anomaly accounting 
for 80 - 90% in both women with recurrent miscarriage (3.5% 
13 
 
prevalence) and in general population. Miscarriage rate associated with 
septate uteri is 65 %. 
Hysteroscopy septoplasty dramatically improved post operative 
pregnancy outcomes. (80% term, 5% preterm, 15% miscarriage). 
15Arcuate uteri are a normal variant. Residual septal defect less than 1 
cm has no adverse effect on pregnancy. 
DES Exposure        
  70 % of women exposed to DES have uterine abnormality. Most 
common uterine abnormality is T shaped uterus, others include 
hypoplastic uterus, irregular intrauterine filling, constriction rings. Most 
exposed women are now beyond their reproductive period, affected 
women are occasionally encountered. The risk of spontaneous 
miscarriage in such women accounts about 24 % and 9 fold increased 
risk of ectopic pregnancy.  
Uterine Leiomyoma 
Uterine fibroids are reported in up to 30% of women, but their 
effect on reproductive outcome is unclear. Uterine fibroid impedes 
embryonic implantation and causes poor regional blood flow. The 
expression of HOX10, a gene  that controls differentiation and is 
14 
 
involved in implantation, is found to be low in uterus with fibroids.16 
Hysteroscopic Myomectomy should be considered in cases of 
submucosal fibroids or any type fibroids larger than 5 cm. Resection has 
been shown to significantly improve live birth rates from 57% to 93%. 
When myoma does not distort the uterine cavity, surgery is not 
indicated in the absence of any other symptoms specific to fibroid. 
INTRAUTERINE ADHESIONS 
        Decreased functional intrauterine volume, endometrial fibrosis 
and inflammation predispose to placental insufficiency. Pregnancy 
outcomes are generally poor. 40 – 80 % results in spontaneous 
miscarriage and 25 % ends in preterm delivery.17 The prognosis 
generally correlates with the severity of the disease. Hysteroscopic 
adhesiolysis dramatically improves the pregnancy outcome.  
CERVICAL  INCOMPETENCE 
  The diagnosis is based on a history of late second trimester 
miscarriage characterized by  painless  cervical dilatation  followed by 
ballooning of membranes  and ultimately resulting in expulsion of fetus. 
Efficient treatment helps in preventing future miscarriage. 
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IMMUNOLOGICAL  PHENOMENON 
 Pregnancy is a immunotolerance state. A subset of CD4 cells that 
describe CD25 on their cell surface. These CD4, CD25 cells are called 
Regulatory T Lymphocytes (T reg cells). T reg cells when activated by 
autoantigens can suppress activated inflammatory cells. 
Cellular Immune Mechanisms 
 Decidual NK cells compromises 70-80% of the total endometrial 
population at the implantation site.  
 Human reproductive tract is populated by TCR Ȗ į +; they are 
increased in early pregnancy; their functions are direct, Non – MHC 
registered recognition of antigens within tissues. Suppressor 
macrophages helps in pregnancy maintenance. They help in promotion 
of anti – inflammatory effect. T reg cells suppress maternal responses to 
self and to the fetus. 
Antigen Presentation at the Maternal  Fetal  Interface 
 Implanting trophoblastic allograft causes down regulation of its 
expression   of the MHC – encoded transplantation antigens and avoid 
recognition as non – self.  Current theory, in placental trophoblast MHC 
class I and II molecules are not expressed.18 
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Extravillous trophoblast express classical MHC class I HLA – C 
and non – classical HLA – E and G products. They are characterized by 
their invasive potential deep into the maternal decidua, an activity 
essential for proper placental development. Aberrant expression of class 
II MHC; over expression of class I MHC leads to cytotoxic Tcell attack, 
could enhance abortion. MHC II genotypes appear to affect 
susceptibility to a variety of diseases, like diabetes and other auto 
immune diseases and adverse pregnancy outcome. 
Regulation of maternal decidual cells 
Regulatory mechanisms include 
i) Alterations in T- helper cell phenotypes 
ii) Reproductive hormones and immunosuppression 
iii) Tryptophan metabolism 
CDT4 cells are divided into TH1 responses and TH2 responses. 
TH1 cells are associated with inflammation. They are harmful to the 
implanting embryo. 
TH2  cells  are  associated  with  IL  –  4,5,6,10   and   antibody  
production; they are important for pregnancy maintenance. 19 
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The dysregulation of their T-helper cellular immune response 
accounts for about 60-80%. Leukemia inhibitory factor is absolutely 
essential for pregnancy maintenance.  
Humoral  Immune  Response 
Patients with recurrent pregnancy loss display altered humoral 
responses to endometrial and trophoblast antigens; Historicaly these IgG 
and IgM antibodies (cardiolipin and phosphatidylserine) are thought to 
be directed against negatively charged phospholipids. More recently the 
high tire of antibodies directed against a protein cofactor, called   ȕ 2 
glycoprotein I  alone is sufficient for diagnosis.  
LABORATORY ASSESSMENT (SAPPORO CRITERIA) 20 
Antiphospholipid antibody syndrome requires   presence of at 
least 1 clinical and 1 laboratory Criterion  
  • Clinical  
1. One or more confirmed episodes of vascular thrombosis (venous, 
arterial, or small vessel). 
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2. Pregnancy morbidity  
¾ Pregnancy complications including 
o 1 or more fetal deaths at greater than 10 weeks of gestation 
of a morphologically normal fetus. 
o One or more premature birth of a normal neonate before 34 
th week because of pre eclamosia, or placental 
insufficiency . 
o  3 or more consecutive pregnancy losses at less than  10 
weeks of gestation. 
• Laboratory (repeated at least 2 times, more than 12 weeks apart) 
¾ Positive plasma levels of the anticardiolipin antibodies (IgG 
orIgM) at medium to high levels 
¾ Positive plasma levels of the lupus anticoagulant 
¾ Anti ȕ2 – glycoprotein 1 antibody of IgG or IgM isotype in 
99th percentile titer  
The incidence of APAs in patients with RPL was between 3-5%; 
Less favourable pregnancy outcome was noted among patients with 
known Systemic Lupus Erythematosus. Anti-thrombotic molecule 
(annexin V) are reduced within the placental villi resulting in 
atherosclerosis in decidual spiral arteries. 
19 
 
THROMBOPHILIAS 
 Abnormal placental vascularisation and inappropriate placental 
thrombosis would relate these thrombophilic states to pregnancy loss. 
The incidence of inherited thrombophilic mutations in  
Caucasians – 15%; 
The most common are 
I) Factor V leiden – 5% 
II) Prothrombin promoter region mutation – 2-3% 
III) Mutation in gene MTHFR – 11-15% .They are associated 
with mild thrombotic risks 
The rare causes are  
I) Anti-Thrombin and  protein  S deficiency. They are 
associated with more severe thrombophilic deficiencies. 
INFECTIOUS CAUSES 
Spontaneous miscarriage has found to be associated with 
Chlamydia trachomatis, Ureaplasma urealyticum or Mycoplasma 
hominis infection. Toxoplasma gondii, Listeria monocytogenes, 
20 
 
Campylobacter species, herpes virus, and cytomegalovirus has also been 
implicated. 
         Many studies has been conducted to correlate the association 
between miscarriage risk and Bacterial vaginosis. There is 5 fold 
increased risk of pregnancy loss before 20 weeks of gestation when 
Bacterial Vaginosis was diagnosed at the first prenatal visit before 14 
weeks.21Chronic subclinical endometritis in women with symptomatic 
lower genital tract infection explains association between infection and 
miscarriage.                     
ENVIRONMENTAL FACTORS 
SMOKING:  Smokers who consume 10 cigarettes / day has 
adverse pregnancy outcome. The anti metabolite composition of 
cigarette like nicotine, carbondioxide  and cyanide may predispose to 
placental insufficiency . 
 ALCOHOL:  Consumption exceeding two drinks / day increases 
the risk. It adds to the additive risk with smoking. 
CAFFEINE:  Heavy caffeine consumption more than 300 mg / 
day, equivalent to 3 cups / day 2 fold increased risk of spontaneous 
miscarriage. 
21 
 
OBESITY: A body mass index equal to or greater than 25 is 
associated with greater risk of miscarriage.22 
Others 
x Anaesthetic gases (Perchorethylene ) 
x Exposure to heavy metals (Mercury,Lead) 
x Isotretinoin (Accutane) 
x Painters and factory workers 
UNEXPLAINED RECURRENT PREGNANCY LOSS 
Even after thorough evaluation, half of the women with recurrent 
miscarriage have no identified predisposing factors. Frequent 
communication, cautious optimism and emotional support during the 
first trimester of the next pregnancy have their own therapeutic value. 70 
-75 % of women ultimately achieve successful pregnancy.   Empiric 
treatment with exogenous progesterone or aspirin in women with 
unexplained recurrent pregnancy loss has no proven value.  
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ENDOCRINE FACTORS 
LUTEAL PHASE DEFECT  
Early pregnancy depends upon the secretion of progesterone from 
corpus luteum till 7 weeks of gestational period. Corpus luteal shift do 
not occur suddenly, it occurs gradually over a period of 7-9 weeks of 
pregnancy.23 The human implantation window is relatively narrow 
approximately 6-10 days after ovulation. Low levels of circulating 
progesterone causes delayed endometrial maturation and causes shift in 
implantation window leading to failed or late implantation.  
Luteal phase defect is diagnosed when there is a persistent delay 
of longer than 2 days in the histologic development of the endometrium 
compared with the respective day of the menstruation. 
          A low progesterone concentration during early pregnancy reflects 
defective corpus luteum, an intrinsically abnormal conceptus or both. 
Serum progesterone concentration fluctuates throughout the day as the 
corpus luteum progesterone secretion is pulsatile. Measurement of 
serum progesterone in early pregnancy to assist the quality of luteal 
function and supporting the risk pregnancy with exogenous progesterone 
therapy are futile.  
23 
 
 Some of the cases of luteal phase defect are associated with hyper 
secretion of luteinizing hormone (LH). Abnormal LH causes premature 
aging of oocyte, dyssynchronous maturation of endometrium, 
improperly timed endometrium at potential implantation sites.24 
 The Luteal phase deficiency is considered as a subtle form of 
ovulation dysfunction . Some prefer to treat with exogenous 
progesterone supplementation starting from 2-3 days after ovulation.25 
POLYCYSTIC OVARIAN DISEASE 
Polycystic ovarian disease are not a characteristic feature of a 
specific endocrine disorder, results from functional derangement in 
follicular development, or by sustained increased intraovarian androgen 
levels as a consequence of  chronic anovulation. 
The National Institute of Child Health and Human Development 
(NICHD) in 1990. 
1. Hyperandrogenism 
2. Menstrual dysfunction 
3. Exclusion of other disorders having a same clinical presentation . 
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The European society for Human Reproduction And Embryology 
(ESHRE) and The American Society Of Reproductive Medicine 
(ASRM) – Rotterdam criteria -2003, at least two of three major criteria 
including, 
1. Oligo/anovulation 
2. Clinical or biochemical signs of hyperandrogenism 
           3.   Polycystic ovaries as identified by ultrasound ( total number 
of follicles, 12 or more measuring 2 – 9 mm in diameter ; ovarian 
volume > 7 – 7.5 m l ) 
Excluding other androgen excess disorders.  
PCOS and INSULIN RESISTANCE 
               The overall prevalence of insulin resistance among with PCOS 
is 50 -75%, greater in obese than in lean individual. 
Methods of measuring insulin sensitivity 
1. Hyperinsulinemic euglycemic clamp  insulin sensitivity is 
defined as the ratio of glucose disposal rate to the steady state 
insulin concentration  
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2. Fasting serum insulin concentration  values more than 20 -30 
µIU /ml suggest insulin resistance. 
3. Fasting glucose / insulin ratio less than 4.5 indicates 
resistance. 
4. Homeostatic model assessment of insulin resistance ( HOMA 
– IR )   values greater than 3.2-3.9 indicates insulin resistance 
5. Quantitative insulin sensitivity check index (QUICKI) 
Inverse of the sum of the fasting glucose and insulin 
concentrations expressed logarithmically; values greater than 0.33 
indicates insulin resistance26 
A  baseline  2   hour  OGTT  is  recommended  for  all  women  with  
PCOS, as up to 35 % exhibit impaired glucose intolerance and up to 10 
% have diabetes.   Hyperinsulinemia and high levels of Plasminogen 
Activation Inhibitor(PAI) activity for the increased incidence of 
miscarriage (30-50%) among women with PCOS. Metformin has also 
found to reduce PAI activity.27 
 Metformin treatment can reduce or eliminate the higher risk of 
miscarriage in women with PCOS relating to an underlying metabolic 
disorder.   
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THYROID HORMONES IN PREGNANCY  
Physiological changes in pregnancy 
                    Moderate enlargement of thyroid gland by glandular 
hyperplasia and increased vascularity during pregnancy, but normal 
pregnancy does not typically cause thyromegaly. 
                    In early first trimester, oestrogen increases the synthesis of 
thyroxine binding globulin. Serum levels of total thyroxine T4 increases 
beginning from 
7 and 9 weeks, and plateau at 18 weeks.  Rise in Free serum T4 levels 
peaks  with hCG levels, later returns to baseline . T3 levels starts 
increasing and reaches peak at 18 weeks later plateaus. TRH levels are 
not increased during normal pregnancy.               
TSH  levels get supressed during pregnancy. This results in 
failure to diagnose women with early hypothyroidism. Inverse 
relationship exists between TSH and hCG . TSH levels drops to a nadir 
at  10  weeks  and  at  the  same  time  hCG  reaches  the  peak.  As  hCG  
decreases later, TSH raises in later part of pregnancy. Fetal thyroid 
gland starts secreting insulin only after 10 – 12 weeks of pregnancy, 
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since then the entire supply and fetal brain development depends on 
maternal source. 
Hypothyroidism in pregnancy (LEON SPEROFF et al ) 28 
            Hypothyroidism, even subclinical have increased risk of 
spontaneous miscarriage. Mechanism being impaired function of 
endometrium, corpus luteum and the placenta. Preconceptional 
screening with achievement of euthyroid state before pregnancy is 
necessary for successful outcome. 
              Universal screening is not routinely recommended. But those 
with elevated TSH levels needs estimation of anti thyroid antibodies. 
Women with positive thyroid antibodies have has an increased risk of 
becoming hypothyroid as pregnancy advances. Women treated for 
hypothyroidism requires an increase in thyroxine during pregnancy 
starting as early as 5 th week of gestation. 
The causes for such an effect are 
1. estrogen induced increase of thyroid binding globulin,  
2. dilutional effect of increase in vascular volume , 
3.  and the increase in placental transport and metabolism. 
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As soon as pregnancy is diagnosed, 30 % increase in levothyroxine dose 
is required . TSH levels should be monitored monthly and adjust levels 
in lower limit of normal range for trimester specific levels . 
Weiwei Wang et al, 29 in  his clinical study included  2899 pregnant 
women in their first trimester were enrolled in the study to find  the 
prevalence of thyroid dysfunction and effectiveness between case – 
finding and universal screening strategies. According  to The Endocrine 
Society Clinical Practice Guideline, the high risk group are excluded . 
 The results of the study states that  the prevalence of hypothyroidism 
was higher among the high risk group  significantly when compared to 
those with no risk factors  (10.7 Vs 7 % ) . Patients with positive titre for 
thyroid antibodies and those with risk factors had increased risk of 
thyroid dysfunction. If  a case-finding strategy is followed for screening 
thyroid function in patients with risk factors, approximately 81.6% 
pregnant women with hypothyroidism were missed. 
N Benhadi et al, 30 In this study, he compared the association  of 
maternal TSH and free thyroxine (FT4) concentrations in early 
pregnancy and the risk of miscarriage. 
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2497 Dutch women were included in this cohort study. TSH, FT4, and 
thyroid peroxidase antibodies(TPO-Ab)  concentrations were 
determined at first booking.  Miscarriage was observed in 27 cases and 
there was an increase in level of mean TSH and FT4 level in cases when 
compared with control group. The risk of miscarriage increased by 60% 
for every doubling in TSH concentration. This association remained 
even after excluding all the confounding factors . 
 There was no relation between Maternal FT4 concentrations and 
miscarriage.  Nearly 5.8%  had TPO-Ab positive status but none of them 
had an adverse pregnancy outcome. TPO-Ab  positive group had 
associated  higher TSH values and their risk for miscarriage decreases 
after  treatment with thyroxine. It finally concludes  that adverse 
pregnancy outcome in thyroid antibody positive status either with or 
without  elevated TSH can be improved with treatment. 
Indian Journal of Medical Sciences, Vol. 62, No. 9, September,  
2008, 31 
 The prevalence of hypothyroidism in women with recurrent first 
trimester are evaluated.  163 non-pregnant women with recurrent first 
trimester miscarriage were included in this case – control study. Thyroid 
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function tests are done and after analysis Hypothyroidism was observed 
in seven cases of  miscarriage group (4.12% )  and one in control group. 
If the thyroid levels were insufficient in women, they have a 
higher risk of miscarriage. Most of the women confirms pregnancy only  
during the last weeks of first trimester, during which the insult has 
already occurred . 
Children born as a result of consanguineous marriage, has a 
higher risk of harbouring defective genes and results in greater risk of 
miscarriage. Consanguinity was observed in 30.67% of miscarriage 
group. Women with personal or family history of thyroid disease or with 
symptoms suggestive of hypothyroidism should be tested for thyroid 
hormone . 
 They concluded that early diagnosis and treatment of  hypothyroidism 
in women  with recurrent first trimester miscarriage will help in 
achieving a better outcome  in subsequent pregnancies. 
Negro R et al, 32  This study evaluated the association of recurrent  
first trimester miscarriage and preterm delivery   between the thyroid 
antibody negative women whose TSH values were  between 2.5 and 5.0 
mIU/liter. They observed a higher incidence of recurrent miscarriage in 
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women with TSH levels more than 2.5 mIU/liter. There was no 
significant differences in the preterm delivery rate.  
Chen L et al, 33 Thyroid autoimmunity(TAI) and miscarriage a 
meta-analysis. 
This study compared the association of thyroid autoimmunity and 
miscarriage rate  with normal thyroid status in women and the effect of 
supplementation with thyroxine in altering their pregnancy  outcomes . 
A systematic review of the studies  was done to compare the association 
between TAI and miscarriage . The prevalence of thyroid autoantibodies   
in women with  recurrent miscarriage was around 17-33%, and in 
women with subfertility it accounts about 10-31%. Even in women with 
euthyroid status, the presence of thyroid peroxidase antibodies, can lead 
to adverse pregnancy outcomes. The proposed are;  
1) Thyroid autoantibodies causes a subtle deficiency, either decrease in 
free thyroxine levels because of chronic lymphocytic thyroiditis or 
inability of the thyroid secretion to meet the demands raised by 
pregnancy and this minor alterations can lead to adverse pregnancy 
outcomes.  
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 2) Presence of thyroid autoantibodies denotes an underlying 
autoimmune state. Thyroid hormones influence the production of 
angiogenic growth factor, cytokine production, trophoblast proliferation, 
and invasion. Dysregulation of such inflammatory processes and 
alterated cytokine expression  leads to miscarriage. These women 
develop subclinical or overt hypothyroidism. 
3) Age is more important as antibody positive status is more common 
in older women than in young. 
    There was a significant association in twenty eight of the 31  studies 
between thyroid autoantibodies and spontaneous miscarriage. The odds 
ratio of miscarriage  was tripled in women with thyroid autoantibodies 
and doubled in women with subfertility.  TSH  levels  were  elevated in  
thyroid autoantibody positive women. Data on serum free thyroxine 
(fT4) and free triiodothyronine (T3) concentrations were insufficient. 
Effect of levothyroxine treatment on pregnancy outcomes, two studies 
were compared, there was 52% risk reduction after treatment  
De  Vivo  A et al, 34 216 pregnant women who had   history of 
miscarriages were included in the study. Patients with known thyroid 
disorders are excluded. Type of miscarriage was divided in to two 
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groups very early (embryonic loss – CRL < 10 mm ) and early ( fetal 
loss – CRL > 10 mm ) . 
 TSH levels were higher among women in very early pregnancy 
losses. Outcome of the study postulated that subclinical hypothyroidism 
and autoimmune disease were independently associated with embryo 
loss, but those who tested positive for subclinical hypothyroidism had 
abortion onset at an early gestation. 
Vaidya  B et al, 35 The efficacy of screening thyroid disorders 
among  pregnant women in their early trimester who belongs to high 
risk group. TSH was found to be higher in high risk women ( 6.8 % Vs 
1 % ) than in low risk. They concluded that about one third of cases will 
be missed if such a screening strategy was followed . 
Haddow JE et  al,  36 Maternal hypothyroidism in early trimester 
of pregnancy is harmful to fetal brain development and causes mental 
retardation, correction of such disorders lead to improvement in the IQ 
scores of children. Maternal thyroid function gains more importance in 
view of screening and early treatment  during the first trimester of 
pregnancy.   
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DIABETES AND PREGNANCY 
 Diabetes is one of the oldest, but most common complication of 
pregnancy and emerging health concern in developing countries as it 
influence the health of mother and the outcome of the fetus. 
         “In earlier days even before the introduction of insulin, Diabetes in 
pregnancy was thought to be incompatible with life and hence diabetic 
women were not allowed  to conceive” 
 Later in 1823 HG Bennewitz, stated  “Diabetes as a symptom of 
pregnancy as the disease appeared along with pregnancy, lasted till the 
duration of pregnancy, and it terminated with delivery”. 
   In 1882, J Mathews Duncan et al, 37 was the first to recognize 
Diabetes in pregnancy as a serious problem with adverse maternal and 
fetal outcome. His observations holds good even today. 
             In 1909, Whitfield Williams et al,38 screened the urine samples 
of all pregnant women and concluded that pregnancy can occur in a 
diabetic women and Diabetes can occur in pregnancy, although both 
remains  a serious problem. 
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             In 1915, Elliot P Joslin et al, 39 he concluded that with 
improvements of treatment in diabetes, pregnancy is less likely to 
develop complications . 
              In early 1970, Norbert  Frienkel  formed “Diabetes in 
pregnancy Centre (DPC)” and he was the one to introduced the concept 
of “Accelerated starvation and facilitated anabolism.” He demonstrated 
that the poor metabolic control at different phases of gestation; In early 
phase of pregnancy–spontaneous abortion and congenital 
malformations, in the middle – psychomotor development, and in late 
pregnancy – macrosomia. 
Maternal Diabetes affects Pre implantation Embryo development 
and oocyte maturation, it causes decreased ovulation, mitotic spindle 
defects, chromosomal misalignments and aneuploidy. Oocyte and 
embryo are vulnerable to acute and chronic hyperglycemia. 
Ryan Ennes et al, 40 In early normal pregnancy there will be a 
rise in both oestrogen and progesterone. Their actions over insulin is 
counter balanced as progesterone results in insulin resistance, whereas 
ostrogen is protective. Diabetes complicates about 10 % of all the 
pregnancies. Diabetes exerts a negative effect on implanting fetus by its  
inflammatory nature, due to oxidative stress and activation of Protein 
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kinase C and Mitogen – activated protein Kinase resulting in improper 
trophoblastic penetration. 
Claudan TD et al, 4 among women with type 2 diabetes only 5 % 
of 61 pregnacies were planned, and in more than 50 % of women  they 
entered the antenatal clinic only in their first trimester. 
Roland et al, 42 observed only 29 % of  diabetic women attended 
pre pregnancy counseling. 
Leptin: Leptin is a 16 kDa protein encoded by obesity gene 
which is secreted from adipose tissue. It is a good marker of insulin 
resistance, it causes both central and peripheral insulin resistance.  
         Laivuori et al, 43 maternal plasma leptin levels increases during 
pregnancy due to associated insulin resistance, and thus any alteration in 
leptin action may lead to development of Diabetes. They also found a 
significant positive correlation between leptin levels and glycosylated 
haemoglobin. 
Dunne et al, 44 out of 182 pregnancies with type 2 diabetes, they 
observed a miscarriage rate of 8.8 % when compared to 15.7 % in 
women with poor diabetic control, a nearly two fold increased risk. 
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           The most often associated teratogenic factors in diabetes are 
hyperglycemia and ketonemia. They lead to alteration in the metabolism 
of inositol, sorbitol, arachidionic acid/ prostaglandins, reactive oxygen 
species and folic acid .  This embryonic glycated proteins along with the 
genetic inheritance determines the chance of embryopathy in pregnancy. 
Organogenesis occurs before 8 weeks of pregnancy before which 
most of the women are unaware of their pregnancy. 
Miller et al, 45 Increase in the level of HbA1c was positively 
correlated with the risk of occurrence of malformation during early 
pregnancy. 
HbA1c Risk  of malformation 
7 – 8.5 % 5.1 % 
8.6 -9.9 % 22.9 % 
Above 10 % 21.7 % 
 
Sheffield et al, 46 in his study concluded that  women with pre 
gestational or gestational diabetes in accordance with fasting 
hyperglycemia has 2 to 3 fold increased risk of developing malformed 
fetus. 
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 Strotmeyer et al, 47   Diabetic women  has increased menstrual  
problems before 30 yrs than control. There was two fold increased risk  
of menstrual problems. Women aged less than 20 yrs and 20 -29 yrs, 
was related to long cycles and increased menstruation. No differences 
was noted after 30 years of age. The results postulated that diabetes was 
an independent risk factor for young women with menstrual 
abnormalities. 
           Obesity is associated with both diabetes and polycystic ovarian 
disease. They generally takes a long time to conceive, irrespective of 
their age and menstrual irregularities . 
              Metwally et al, 48 observed that oocytes of women with 
increased body mass index would give rise to poor quality of 
blastocysts. 
  Robker et  al , 49  found that women with increased body mass 
index have increased levels of intrafollicular insulin and triglycerides, 
free androgen profile, C – reactive protein  and increased expression of 
lipoprotein receptors  which contributes to the poor obstetric outcome. 
Mille JL et al,50 This study was conducted to determine the 
association whether women with insulin dependent diabetes  have an 
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increased risk of  spontaneous abortion and to know the relationship 
between good glycemic metabolic control and loss of pregnancy in 
diabetics. 
Miscarriage was observed in 16 % of both diabetic and non-
diabetic women. After excluding the other known confounding factors 
that would cause spontaneous miscarriage, still there was no 
significance. But things observed in this study are, among the diabetic 
women with good glycemic control, and who ended in  abortion had 
both an increase in their  fasting and postprandial blood sugar  levels in 
the first trimester when compared to those women who achieved their 
good glycemic control before conception . 
           In diabetic women with poor glycemic control, there was an 
associated increase of 3.1% rate of miscarriage with increased  
glycosylated hemoglobin. 
This study concludes by confirming that women  in their first 
trimester with a poor glycemic control have a higher  risk of 
miscarriage.  
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The Multicenter Diabetes in Early Pregnancy  ( DIEP ) study 
observed increased risk of spontaneous miscarriage from 9 % to 45 % in 
women with poor glycemic control in first trimester . 
           Temple et al, 51among 242 patients, glycosylated hemoglobin > 
7.5 %  results in four fold increased risk of spontaneous abortion than 
control . 
              Ivanisevic et al, 52 delayed embryonic growth in women with 
type 1 diabetes has eight fold higher risk of miscarriage than women 
with normal fetal growth . Their HbA1c levels were 9.34 % in women 
with poor metabolic control  
 Schoenfeld et al, 53 Diabetes causes reduction in the turn over of 
phosphatidyl inositol, disruption of arachidionic acid cascade, and later 
prostaglandin deficiency. Undetectable prostaglandin levels in the yolk 
sac was observed in diabetic women who had a spontaneous abortion in 
their early trimester. The free radical oxidative process leads to 
conceptus  damage, embryonic death and abortion . 
           Ben – haroush  A, Fisch B et al,54 increased glucose levels 
alters the gene expression, resulting in programmed cell death of key 
progenitor cells which ends in miscarriage . 
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Miodovnik M et al,55 Good levels of glycemic control in between 
pregnancies was associated with better obstetric outcomes and prevents 
the mental agony of the mother resulting in miscarriage. 43 women with 
diabetes were enrolled in this study. Fasting and postprandial blood 
sugars, HbA1c were collected at 9 weeks of gestation. 20 women 
resulted in term pregnancies  and 15 ended in abortion. In women who 
had term  pregnancies, the levels of postprandial blood sugar and 
glycosylated haemoglobin levels were significantly lower than who 
ended in abortion .   
Strotmeyer et al,47 more than 40 % of women with type 1 
diabetes had associated   Hashimoto’s  thyroiditis  ( type 2 polyglandular 
failure associated with antibodies to multiple endocrine organs). women 
with corrected thyroid abnormalities were less likely to develop 
menstrual disturbances. 
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PROLACTIN AND PREGNANCY 
Prolactin is secreted by anterior pituitary  lactotrophs. It is an 
unique hormone among others, as its secretion is controlled by tonic 
inhibition. 
Stimulating factors  
¾ Thyroid-releasing hormone (TRH),  
¾ Gonadotropin-releasing hormone (GnRH) 
¾ Hypothalamic  serotonergic  pathway 
¾ g-aminobutyric acid (GABA) 
¾ Estrogens, 
¾ Pregnancy, and 
¾ Breast suckling  
¾ Chronic renal disease 
¾ Pituitary adenoma /hypothalamic tumours 
Pharmacologic agents that cause prolactin release act either by 
blockade of dopamine receptors (e.g., haloperidol, phenothia-zines)  
or by dopamine depletion in the tuberoinfundibular neurons  
(e.g., reserpine).  
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Other factors: Angiotensin II, Histamine (H2) antagonists, and 
opiates. Prolactin secretion has a diuranal variation with increase in 
pulsatile secretion during sleep. 
Inhibiting factors   
Increased levels of dopamine. 
Human prolactin has  partial structural similarity to Growth 
Hormone, this accounts for the lactotropic activity of growth hormone. 
Two forms of prolactin are found in the circulation- Non-glycosylated 
(monomeric & polymeric ) and glycosylated. 85 % of prolactin (23 kDa)  
secreted into serum is non-glycosylated,.  
The polymeric forms of prolactin ( big prolactin ) have reduced 
rates of binding to the prolactin receptor and possess decreased  
bioactivity when compared to  monomeric.  Some patients with elevated 
prolactin levels can have normal reproductive function;  this group of 
patients have increased polymeric forms. 
 Certain isotypes of prolactin, specifically iso-B prolactin, is 
found to be elevated in the  patients with infertility and pregnancy 
wastage. This isotype is also found to be more resistant to bromocriptine 
therapy when compared with normal .  Circulating prolactin in turn 
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stimulates the hypothalamic dopaminergic neuronal activity, which 
suppresses both prolactin and GnRH neurons. 
Grades of hyperprolactinemia  ( Leon speroff et al,) 
Mild 20 -50 ng/ml short luteal phase, poor preovulatory 
folliculogenesis 
Moderate 50 -100 ng/ml  oligo /amennorhoea 
Severe >100ng/ml Frank hypogonadism (decreased 
estrogen ). 
 
In normal pregnancy, prolactin increases by 10 fold reaching 
about 200 – 400 ng/ ml by term. The levels of increased estrogen in turn 
cause a rise in prolactin by stimulating pituitary lactotrophs. Both the 
rise of prolactin and estrogen  nearly parallels by 7 – 8 weeks, this 
occurs as estrogen inhibits the prolactin inhibiting factor,  Dopamine 
and leads to activation of transcription gene promoter gene of prolactin.  
            The source of prolactin in pregnancy comes from maternal 
pituitary, uterine decidua, and the fetal pituitary. Uterine decidual 
synthesis  of prolactin is also secreted in to amniotic fluid. This levels 
reaches a peak at 26 – 28 weeks of gestation it later falls to a nadir after 
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34 weeks. Prolactin  prevents water from being transferred from the fetal 
to the maternal circulation thereby preventing fetal dehydration. 
TREATMENT OF HYPERPROLACTINEMIA  
Bromocriptine  
        It is a dopamine agonist. It is used to normalize the prolactin 
irrespective of the etiology leading to the disorder. Treatment with 
Bromocriptine  showed return of ovulatory menstrual cycles in 80 – 90 
%, diminished prolactin levels, return of reproductive function  
(Molitch ME et al )56 
  Onset of action is rapid within 1 -2 hours ; starts decreasing as 
soon as initiation of theraphy.  Sudden discontinuation may lead to  
return to elevated levels. They are usually started at the lowest dose 
1.25mg daily at night and gradually increased until the dose that cause a 
decrease in prolactin level is reached. Gastrointestinal side effects are 
common.  It can be reduced by administering the drug vaginally and the 
efficacy is relatively higher with vaginal route( Vermesh M et al)57 
 Cabergoline ,an ergot derivative, long acting dopaminergic 
properties, less side effects, less frequent dosing (1mg once or twice 
weekly), higher compliance rate. Normalization of prolactin leval occurs 
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in 95 % ( Bassetti  M  et  al).58 This drug plays an important role in 
patients intolerant or resistant to Bromocriptine 
Seppala M et al, 59 This study demonstrated a diminished plasma 
progesterone levels in women with hyperprolactinemia than their control 
in the ovulatory cycles. They had onset of symptoms which occurred in 
a specific sequence like  1) short luteal phase 2) galactorrhoea  
3) ovulatory disturbances  4) Menstrual irregularities which forms the 
typical amenorrhoea-galactorrhoea syndrome. They found that these 
symptoms resolved with the initiation of treatment with bromocriptine. 
 Homburg R,et al, 60 it was previously thought that only short 
luteal phase and polycystic ovaries played a role in spontaneous 
miscarriage, but recently hypersecretion of luteinizing hormone has 
been implicated to play a key role in recurrent pregnancy loss. 
 Ando N, Gorai I et al, 61 In their study, they found many women 
with elevated prolactin levels duing their routine comprehensive 
screening for recurrent miscarriage. 
Asukai K et al, 62 Hypothalamic – pituitary  ovarian system is 
affected by  hyperprolactinemia or occult hyperprolactinemia. This 
causes impaired folliculogenesis  and abnormal maturation of oocyte. 
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This impaired process is found to be reversed with administration of 
Bromocriptine. 
Yamaguchi  M  et  al,63 They concluded that patients with 
hyperprolactinemia ultimately in due course of time develops luteal 
insuffiency, galactorrhoea and  dysfunction in reproductive 
endocrinology.  Those patients who has both elevated prolactin levels 
and luteal phase defect responds better with Bromocriptine. 
Fumiki  Hirahara, M.D et al, 64 They reported that a profound 
group of women  with repeated  miscarriage  had abnormal prolactin 
levels with no disturbances in  their ovarian or menstrual function . They 
initially evaluated serum prolactin in two different menstrual cycles 
during the mid-follicular phase in the day time, women with abnormal 
values were subjected to endometrial biopsy. 
12 women were found in hyperprolactinemia and occult 
hyperprolactinemia. They were started on Bromocriptine   and prolactin 
levels were brought down to normal levels. Patients who conceived 
during the course of  theraphy were continued with bromocriptine till 9 
weeks of gestation. The success rate of  85.7 % and 52.4 %  of livebirths 
were observed  in those who were treated and  not treated respectively. 
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  They concluded that maintenance of normal levels of prolactin is 
essential in early pregnancy and Bromocriptine has a significant role in 
the therapeutic strategy of such patients with recurrent miscarriage.  
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MATERIALS AND METHODS 
  This study was conducted among 100 patients  who attended the 
Genetic clinic, The Department of Obstetrics and Gynaecology in 
Government Kilpauk Medical College Hospital, Chennai. Ethical 
committee clearance obtained on Febraury 2011. Study period : 
February 2011 to September 2012. 
This study was done after obtaining ethical committee clearance 
conducted in Kilpauk Medical College Hospital. 
 Sample size: 100, sample size was calculated by, 
n =  Z 2 1 – Į/2           P(1 – P) / d 2 
where, n – sample size 
            Z- table value, 1.96 
            P- proportion in a given population 
            d- desired precision, 0.05 
About 100 patients  are selected, after a complete evaluation of 
history, clinical examination and all basic investigations, they are 
subjected to the study.  
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INCLUSION CRITERIA 
 Women with previous history  of  two or more abortions that 
occurred in the first trimester among the reproductive age group were 
included 
EXCLUSION CRITERIA 
1) Second trimester abortions. 
2) Women who conceived after Assisted Reproductive 
Technologies. 
3) Previous ectopic pregnancies. 
4) Previous molar pregnancies. 
5) Known diabetic patients. 
6) Known patients with thyroid disorders.  
7) Women taking Anti – psychotics. 
METHODOLOGY  
          After selection of 100 women based on the inclusion criteria, the 
patient was explained about the study and after obtaining the consent, 
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they are subjected to the study. Detailed history was taken to evaluate 
the presence of risk factors . A thorough general and  systemic 
examination was done. All basic clinical investigations were performed .                  
Blood samples are collected and assayed for the following tests  
                  1.Thyroid stimulating hormone. 
                  2.Serum prolactin. 
                  3.Glucose  Tolerance test. 
  Reports are evaluated and the prevalence of each disorder is 
correlated with the casuation of Recurrent pregnancy loss.    
Patients were advised to come in their fasting states. They were 
advised not to eat, drink, or exercise strenuously for atleast 8hours and 
be in rest during  the test. 
Thyroid stimulating hormone assay  ( LEON SPEROFF et al ) 
•  Non-pregnant adult 0.34- 4.25 µIU/ml 
•  1st trimester 0.3 -2.30µIU/ml 
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PROLACTIN 
• Non –pregnant adult 20 ng/ml 
•  1st trimester 36- 213 ng/ml  
GLUCOSE TOLERANCE TEST   
x NON – PREGNANT WOMEN : ADA recommends a 75g OGTT 
with plasma glucose measurement at fasting and 2hr. Blood sugar 
was estimated by GOD-POD method. 
 Normal Impaired glucose 
Intolerance 
Diabetes 
Mellitus 
Fasting <100 100 -126 >126 
2 hour <140 140 - 200 >200 
 
x PREGNANT - WOMEN: 2 hour 75gm oral glucose, a venous 
blood glucose level of 140mg % or more is considered diagnostic. 
(Journal of Obstetrics and Gynaecology of India,Vol – 62). 
The final data of all risk factors were expressed in percentages . 
statistical analysis was done with chi–square test and students 
independent T – test. The analysis was taken as statistically significant if 
pvalue < 0.05. 
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RESULTS AND ANALYSIS 
THYROID AND RECURRENT MISCARRIAGE 
Table: 1 Distribution of Thyroid Dysfunction among  
different age groups 
             TSH 
Total 0 1 
AGE 
GROUP 
1 
19-24yrs 
Count 18 9 27 
% within 
TSH 
22.20% 47.40% 27.00% 
% of Total 18.00% 9.00% 27.00% 
2 
25-29yrs 
Count 38 8 46 
% within 
TSH 
46.90% 42.10% 46.00% 
% of Total 38.00% 8.00% 46.00% 
3 
30-34yrs 
Count 18 2 20 
% within 
TSH 
22.20% 10.50% 20.00% 
% of Total 18.00% 2.00% 20.00% 
4 
>35yrs 
Count 7 0 7 
% within 
TSH 
8.60% 0.00% 7.00% 
% of Total 7.00% 0.00% 7.00% 
Total 
Count 81 19 100 
% within 
TSH 
100.00% 100.00% 100.00% 
% of Total 81.00% 19.00% 100.00% 
Pearson chi-square value: 6.376; p value 0.095 (not significant).  
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Figure 3: Distribution of Thyroid Dysfunction  
among different age groups 
 
Patients with hypothyroidism comprises of about 47.4 % in the 
age group 1, 42.1 % among age group 2, 10.5 % among age group 3. 
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MENSTRUAL ABNORMALITY 
Table 2: Relationship between Menstrual abnormality and  
Thyroid Dysfunction 
  TSH 
Total 0 1 
MENSTRUAL 
0 
Count 59 7 66 
% within 
TSH 
72.80% 36.80% 66.00% 
% of Total 59.00% 7.00% 66.00% 
1 
Count 22 12 34 
% within 
TSH 
27.20% 63.20% 34.00% 
% of Total 22.00% 12.00% 34.00% 
Total 
Count 81 19 100 
% within 
TSH 
100.00% 100.00% 100.00% 
% of Total 81.00% 19.00% 100.00% 
Pearson value 8.887;   p value 0.004 (significant) 
Among patients with recurrent pregnancy loss, in women without 
menstrual irregularities 36,8 %  had hypothyroidism ,whereas in women 
who had menstrual disturbances,63.2 %  had hypothyroidism. The  
association of menstrual disturbances among women with 
hypothyroidism in recurrent pregnancy loss is  statistically significant. 
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INFERTILITY  
Table 3: Relationship between Infertility and Thyroid Dysfunction 
  TSH 
Total 0 1 
INFERTILITY 
0 
Count 73 11 84 
% within 
TSH 
90.10% 57.90% 84.00% 
% of Total 73.00% 11.00% 84.00% 
1 
Count 8 8 16 
% within 
TSH 
9.90% 42.10% 16.00% 
% of Total 8.00% 8.00% 16.00% 
Total 
Count 81 19 100 
% within 
TSH 
100.00% 100.00% 100.00% 
% of Total 81.00% 19.00% 100.00% 
Pearson Chi-Square  11.894  ; p value  0.002 ( significant ) 
In women with recurrent pregnancy loss, with previous  h/o 
infertility  hypothyroidism was observed in 42 .1 %, and  in patient with 
no such risk factors hypothyroidism was observed in 57.9% . 
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Figure 4: Relationship between  Infertility and Thyroid Dysfunction 
 
In  women with recurrent pregnancy loss with previous history of 
infertility almost half of the women had thyroid dysfunction. There 
exists statistical significance  between  occurrence of thyroid 
dysfunction among women with infertility and recurrent pregnancy loss. 
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Table 4: Association of Thyroid Dysfunction and  
Recurrent Miscarriage 
  TSH 
Total 0 1 
 
PREVIOUS 
NUMBER 
OF 
ABORTION 
2 
Count 27 2 29 
% within 
TSH 
33.30% 10.50% 29.00% 
% of Total 27.00% 2.00% 29.00% 
3 
Count 26 2 28 
% within 
TSH 
32.10% 10.50% 28.00% 
% of Total 26.00% 2.00% 28.00% 
4 
Count 23 11 34 
% within 
TSH 
28.40% 57.90% 34.00% 
% of Total 23.00% 11.00% 34.00% 
5 
Count 2 3 5 
% within 
TSH 
2.50% 15.80% 5.00% 
% of Total 2.00% 3.00% 5.00% 
6 
Count 1 1 2 
% within 
TSH 
1.20% 5.30% 2.00% 
% of Total 1.00% 1.00% 2.00% 
9 
Count 2 0 2 
% within 
TSH 
2.50% 0.00% 2.00% 
% of Total 2.00% 0.00% 2.00% 
Total 
Count 81 19 100 
% within 
TSH 
100.00% 100.00% 100.00% 
% of Total 81.00% 19.00% 100.00% 
Pearson Chi-Square Value   16.437  ;  p value  0.006 ( significant ) 
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In  recurrent miscarriage population , women with previous two 
and three  abortions, hypothyroidism was noted in 10.5% of each group ; 
women with previous four abortions, hypothyroidism  was noted in 
57.9% ; and in women with previous five abortions, hypothyroidism 
was observed in 15.8 %, women with more than 6 abortions, 
hypothyroidism was noted in 5.3 % 
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Figure 5: Association of Thyroid Dysfunction with  
Recurrent Miscarriage 
 
 In women with recurrent pregnancy loss, the number of abortions 
has a statistical significance with the occurrence of hypothyroidism, 
especially there is an higher association of hypothyroidism when the 
number of abortion is more than four. 
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FAMILY HISTORY OF THYROID  
Table 5: Association of Thyroid Dysfunction in women  
with Family History of Thyroid 
 TSH 
Total 0 1 
FH/THYROID 
0 
Count 72 13 85 
% within 
TSH 
88.90% 68.40% 85.00% 
% of Total 72.00% 13.00% 85.00% 
1 
Count 9 6 15 
% within 
TSH 
11.10% 31.60% 15.00% 
% of Total 9.00% 6.00% 15.00% 
Total 
Count 81 19 100 
% within 
TSH 
100.00% 100.00% 100.00% 
% of Total 81.00% 19.00% 100.00% 
Pearson chi – square value : 5.057  ; p value  0.036 ( significant) 
In women with family history of thyroid dysfunction, nearly 31.6 
% had hypothyroidism in patients with recurrent miscarriage. 
Family history of thyroid is a significant risk factor for 
development of hypothyroidism in women with recurrent pregnancy loss 
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Group Statistics 
Table 6: The correlation between the occurrence of abortion  
and its association with hypothyroidism 
 
TSH N Mean 
Std. 
Deviation 
Std. Error 
Mean 
ABORTION 
1 19 3.95 0.97 0.223 
0 81 3.19 1.305 0.145 
 
Independent Samples Test 
  Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of 
Means 
F Sig. T Df 
Sig.  
(2-tailed) 
ABORTION 
Equalvariances 
assumed 
1.71 0.19 2.39 98 0.019 
Equal 
variances not 
assumed 
2.87 35.09 0.007 
 
The association between the women with recurrent miscarriage 
and hypothyroidism was analyzed with independent T – test and was 
also found to be statistically significant. 
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DIABETES AND RECURRENT MISCARRIAGE 
AGE GROUP 
Table 7:  Distribution of Diabetes Mellitus among  
different age groups 
  GTT 
Total 0 1 
AGE 
GROUP 1 
19 - 24 
Yrs 
Count 27 0 27 
% within 
GTT 
28.40% 0.00% 27.00% 
% of Total 27.00% 0.00% 27.00% 
2 
25 - 29 
yrs 
Count 45 1 46 
% within 
GTT 
47.40% 20.00% 46.00% 
% of Total 45.00% 1.00% 46.00% 
3 
30 - 34 
yrs 
Count 18 2 20 
% within 
GTT 
18.90% 40.00% 20.00% 
% of Total 18.00% 2.00% 20.00% 
4 
>35   
Yrs 
Count 5 2 7 
% within 
GTT 
5.30% 40.00% 7.00% 
% of Total 5.00% 2.00% 7.00% 
Total 
Count 95 5 100 
% within 
GTT 
100.00% 100.00% 100.00% 
% of Total 95.00% 5.00% 100.00% 
Pearson chi – squarevalue:  11.435; p value:   0. 010 (significant). 
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 In women with recurrent miscarriage, 20 % of Diabetes was 
observed among age group 2 and 40% of  Diabetes belongs to age  
group 3 & 4.  
Figure 6:  Distribution of Diabetes Mellitus among  
different age groups 
 
 
From this data, it is inferred that diabetes occurs mainly in the age 
group above 30.  Diabetes has a significant association in women with 
recurrent pregnancy group especially among older age group. 
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MENSTRUAL ABNORMALITY 
Table 8: Association between Menstrual abnormality  
and Diabetes Mellitus 
  GTT 
Total 0 1 
MENSTRUAL 
0 
Count 65 1 66 
% within 
GTT 
68.40% 20.00% 66.00% 
% of Total 65.00% 1.00% 66.00% 
1 
Count 30 4 34 
% within 
GTT 
31.60% 80.00% 34.00% 
% of Total 30.00% 4.00% 34.00% 
Total 
Count 95 5 100 
% within 
GTT 
100.00% 100.00% 100.00% 
% of Total 95.00% 5.00% 100.00% 
Pearson Chi-Square value: 4.963; pvalue: 0.026 (significant) 
Among women with menstrual disturbances, 80 % had diabetes, 
whereas in women without menstrual disturbances, 20 % had diabetes. 
There exists statistical significance between menstrual disturbances and 
Diabetes in women with recurrent miscarriage especially this was 
observed in women with higher body mass index which causes 
ovulatory dysfunction. 
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INFERTILITY  
Table 9:Relationship between Infertility and Diabetes Mellitus 
  GTT 
Total 0 1 
INFERTILITY 
0 
Count 80 4 84 
% within 
GTT 
84.20% 80.00% 84.00% 
% of Total 80.00% 4.00% 84.00% 
1 
Count 15 1 16 
% within 
GTT 
15.80% 20.00% 16.00% 
% of Total 15.00% 1.00% 16.00% 
Total 
Count 95 5 100 
% within 
GTT 
100.00% 100.00% 100.00% 
% of Total 95.00% 5.00% 100.00% 
Pearson Chi-Square value:  0.063; pvalue:  0.082 (not significant) 
In women with recurrent miscarriage, patients with previous 
history of infertility.  Diabetes  was observed in 20% ,  in patient with 
no such risk factors Diabetes was reported in 80% . 
 
67 
 
Figure 7:Relationship between Infertility and Diabetes Mellitus 
 
 
There is no statistical significance between infertility and 
Diabetes in women with recurrent pregnancy loss 
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Table 10: Association of Diabetes Mellitus with 
 Recurrent Miscarriage 
  GTT 
Total 0 1 
PREVIOUS 
NUMBER OF 
ABORTION 
2 
Count 28 1 29 
% within 
GTT 
29.50% 20.00% 29.00% 
% of Total 28.00% 1.00% 29.00% 
3 
Count 26 2 28 
% within 
GTT 
27.40% 40.00% 28.00% 
% of Total 26.00% 2.00% 28.00% 
4 
Count 33 1 34 
% within 
GTT 
34.70% 20.00% 34.00% 
% of Total 33.00% 1.00% 34.00% 
5 
Count 5 0 5 
% within 
GTT 
5.30% 0.00% 5.00% 
% of Total 5.00% 0.00% 5.00% 
6 
Count 1 1 2 
% within 
GTT 
1.10% 20.00% 2.00% 
% of Total 1.00% 1.00% 2.00% 
9 
Count 2 0 2 
% within 
GTT 
2.10% 0.00% 2.00% 
% of Total 2.00% 0.00% 2.00% 
Total 
Count 95 5 100 
% within 
GTT 
100.00% 100.00% 100.00% 
% of Total 95.00% 5.00% 100.00% 
Pearson chi – square value  9.616 p value  0.087 (not significant) 
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Figure 8: Association of Diabetes Mellitus with   
Recurrent Miscarriage 
 
 
There is no significant association between the occurrence of 
abortion  and  Diabetes in women with recurrent pregnancy loss 
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FAMILY HISTORY OF DIABETES 
Table 11: Association of Diabetes Mellitus in women with  
Family History of Diabetes 
 
 
GTT 
Total 0 1 
FH/DM 
0 
Count 84 4 88 
% within 
GTT 
88.40% 80.00% 88.00% 
% of Total 84.00% 4.00% 88.00% 
1 
Count 11 1 12 
% within 
GTT 
11.60% 20.00% 12.00% 
% of Total 11.00% 1.00% 12.00% 
Total 
Count 95 5 100 
% within 
GTT 
100.00% 100.00% 100.00% 
% of Total 95.00% 5.00% 100.00% 
Pearson Chi – Square value : 0.319; pvalue:  0.572(not significant) 
 In women without family history of  Diabetes ; diabetes was 
observed in 80 % of patients, And in those with family history, it was 
observed in 20 %. 
In this study, there is no statistical significance between family 
history of diabetes and occurrence of diabetes among patients with 
recurrent pregnancy loss .  
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PROLACTIN AND RECURRENT MISCARRIAGE 
Table 12:Association between Menstrual abnormality and  
Prolactin Disorders 
MENSTRUAL IRREGULARITIES 
  PROLACTIN 
Total 0 1 
MENSTRUAL 
0 
Count 66 0 66 
% within 
PROLACTIN 
68.00% 0.00% 66.00% 
% of Total 66.00% 0.00% 66.00% 
1 
Count 31 3 34 
% within 
PROLACTIN 
32.00% 100.00% 34.00% 
% of Total 31.00% 3.00% 34.00% 
Total 
Count 97 3 100 
% within 
PROLACTIN 
100.00% 100.00% 100.00% 
% of Total 97.00% 3.00% 100.00% 
Pearson Chi-Square value:  6.004; pvalue:  0.014 (significant) 
All women who were diagnosed to have hyperprolactinemia in 
this population, there was 100% association with menstrual 
disturbances.  Menstural disorders in woman with recurrent pregnancy 
loss have a statistically significant association with prolactin disorders. 
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INFERTILITY  
Table 13:Association between  Infertility and Prolactin disorders 
  PROLACTIN 
Total 0 1 
INFERTILITY 
0 
Count 84 0 84 
% within 
PROLACTIN 
86.60% 0.00% 84.00% 
% of Total 84.00% 0.00% 84.00% 
1 
Count 13 3 16 
% within 
PROLACTIN 
13.40% 100.00% 16.00% 
% of Total 13.00% 3.00% 16.00% 
Total 
Count 97 3 100 
% within 
PROLACTIN 
100.00% 100.00% 100.00% 
% of Total 97.00% 3.00% 100.00% 
Pearson chi – square value:  16.237;  pvalue:  0.000 ( significant ) 
Among woman with recurrent pregnancy loss with previous 
history of infertility, there was 100% association with elevated prolactin 
levels.  
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Figure 9: Association between Infertility and Prolactin disorders 
 
 
There exists a higher statistical significance with previous history 
of infertility and hyperprolactinemia in woman with recurrent pregnancy 
loss. 
 
 
 
 
Normal
High
0
20
40
60
80
100
0
1
PROLACTIN
INFERTILITY
Normal
High
74 
 
Table 14: Association of Hyperprolactinemia with  
Recurrent Miscarriage 
  PROLACTIN 
Total 0 1 
PREVIOUS 
NUMBER 
OF 
ABORTION 
2 
Count 28 1 29 
% within 
PROLACTIN 
28.90% 33.30% 29.00% 
% of Total 28.00% 1.00% 29.00% 
3 
Count 28 0 28 
% within 
PROLACTIN 
28.90% 0.00% 28.00% 
% of Total 28.00% 0.00% 28.00% 
4 
Count 33 1 34 
% within 
PROLACTIN 
34.00% 33.30% 34.00% 
% of Total 33.00% 1.00% 34.00% 
5 
Count 4 1 5 
% within 
PROLACTIN 
4.10% 33.30% 5.00% 
% of Total 4.00% 1.00% 5.00% 
6 
Count 2 0 2 
% within 
PROLACTIN 
2.10% 0.00% 2.00% 
% of Total 2.00% 0.00% 2.00% 
9 
Count 2 0 2 
% within 
PROLACTIN 
2.10% 0.00% 2.00% 
% of Total 2.00% 0.00% 2.00% 
Total 
Count 97 3 100 
% within 
PROLACTIN 
100.00% 100.00% 100.00% 
% of Total 97.00% 3.00% 100.00% 
Pearson chi – square value  5.976 ; p value  0.309 ( not significant ) 
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Figure 10: Association of Hyperprolactinemia with  
Recurrent Miscarriage 
 
   Hyperprolactinemia was observed in 33.3%   in woman with  
previous history of 2, 4 and 5 abortions. There is no statistically 
significant association between number of abortion and 
hyperprolactinemia 
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 FAMILY HISTORY OF THYROID 
Table 15: Association of Prolactin Disorders in women with  
Family History of  Thyroid 
  PROLACTIN   
0 1 Total 
FH/THYROID 
 
 
 
 
 
 
 
 
 
 
 
 
0 
Count 84 1 85 
% within 
PROLACTIN 
86.60% 33.30% 85.00% 
% of Total 84.00% 1.00% 85.00% 
1 
Count 13 2 15 
% within 
PROLACTIN 
13.40% 66.70% 15.00% 
% of Total 13.00% 2.00% 15.00% 
Total 
Count 97 3 100 
% within 
PROLACTIN 
100.00% 100.00% 100.00% 
% of Total 97.00% 3.00% 100.00% 
Pearson chi – square value:  6.475; pvalue: 0.058 (significant) 
In women with family history of hypothyroidism, 
hyperprolactinemia was observed in 66.7 % of individuals, whereas it 
was noted only in 33. 3 % of individuals with no family history of 
thyroid dysfunction 
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PRIMARY AND SECONDARY MISCARRIAGE 
Figure 11 
 
89 patients of primary and 11 patients of secondary miscarriage 
were included 19 antenatal patients were included, of which13 delivered 
term, 4 preterm, one intra uterine death, and one  patient had recurrent 
miscarriage 
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Figure 12: GESTATIONAL AGE AT ABORTION 
 
 
Among the study group, the gestational age of abortion is divided 
in to two groups, 42% of miscarriage occurred in 6 – 9 weeks and 58% 
of the miscarriage occurred in 9 -12 weeks. 
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Table 16: The correlation between the age group and  
the occurrence of abortion 
Age group and abortion 
  95% Confidence 
Interval for Mean   
  
N Mean 
Std.  
Deviati
on 
Std. 
Error 
Lower 
Bound 
Upper 
Bound 
Mini-
mum 
Maxi- 
mum 
1 27 2.74 0.813 0.156 2.42 3.06 2 4 
2 46 3.09 0.939 0.138 2.81 3.37 2 5 
3 20 4.35 1.785 0.399 3.51 5.19 2 9 
4 7 4.29 0.951 0.36 3.41 5.17 3 6 
Total 100 3.33 1.28 0.128 3.08 3.58 2 9 
 
ANOVA 
ABORTION 
  Sum of 
Squares Df 
Mean 
Square F Sig. 
Between 
Groups 
39.294 3 13.098 10.238 0.00 
Within 
Groups 
122.816 96 1.279 
Total 162.11 99 
 
The association of recurrent pregnancy loss among women with 
higher age group was found to be statistically significant. 
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Table 17: Correlation between BMI and abortion 
Correlations 
  ABORTION BMI 
ABORTION Pearson Correlation 1 .255* 
Sig. (2-tailed) 0.01 
N 100 100 
BMI Pearson Correlation .255* 1 
Sig. (2-tailed) 0.01 
N 100 100 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
The correlation between women with recurrent pregnancy loss 
and those with higher body mass index was found to be statistically 
significant. 
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DISCUSSION 
Among women with recurrent pregnancy loss, 100 patient was 
evaluated and results that were obtained were tabulated and subjected to 
analysis. The following results are observed at the end of the study. 
In this study; in relation to age group and recurrent pregnant loss; 
Hypothyroid was higher among 19 – 24 age groups (47.4%) and 
Diabetes was found to occur in age group of population more than 30 
years (80%). 
 Considering the age of the patients included in this population, 
there was an associated higher statistical significance between the age of 
the patient and the occurrence of abortion (pvalue 0.000). As the age 
increases, patients with previous history of recurrent pregnancy loss are 
highly susceptible to recurrent abortions. 
 Anne Marie et al., (conducted a population based register – 
linear study) BMJ, 24, June 2000; 65 which also inferred that  as 
Maternal age increases, the risk of spontaneous abortion also increases 
proportionally. They observed 8.9% risk of miscarriage in women of 20 
– 24 years. 74.7% risk in women more than 45 years. 
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In women with menstrual irregularities among recurrent 
pregnancy loss group; there observed statistically significant association 
of 63.2% with hypothyroidism; 80% with Diabetes; and 100% with 
prolactin disorders. In women with Diabetes, 80% of the population 
with irregular menstrual cycles had an average Body Mass Index of 
more than 28 which attributes to their menstrual disturbances. 
This finding is also compared with the latest study conducted by 
Neha Sharma et al, 66 International Journal of Science and Research, 
2012 they found that Thyroid Stimulating Hormone had a higher 
statistical significance (pvalue <0.01) in women with menstrual 
disturbances and infertility. 
In recurrent miscarriage women; with previous history of 
infertility, there was a statistical significance associated with Thyroid 
and prolactin disorders (100%- pvalue: 0.000). 
 Hakim et al; 67 observed that women who are infertile have a 
greater risk of recurrent miscarriage when compared to women who are 
fertile. 
The same result was observed in the study performed by  
Azima Kalsum et   al; 68   which reported 69.51% of women who had 
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prolactin disorders reported with infertility; and Homburg R et al 60 
implicated the role of prolactin disorders in women with recurrent 
pregnancy loss. 
The number of abortion has a higher statistical correlation 
(pvalue:  0.006) in women who tested positive for Thyroid dysfunction, 
especially in women with previous history of 4 abortions.  
Ashoor et al, 69 women with miscarriage had higher TSH levels 
(5.9 vs 2.5%, pvalue < 0.05). Indian Journal of Medical Sciences, 
observed that the association of hypothyroidism with recurrent 
miscarriage were found to be statistically significant (pvalue < 0.001). 
Vinita et al, 70 found hypothyroidism in 1.4% of women with 
recurrent miscarriage in Indian population. 
Stray Pederson et al, 71 observed thyroid dysfunction in 2% of 
women with recurrent miscarriage. 
This was also observed in the study performed by Regan et al; 4 
He stated that the outcome of a women’s first pregnancy is also 
considered as a predictive factor and this also influence the outcome of 
subsequent pregnancies. 
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Family history of Thyroid also had a statistical significance 
between the occurrence of hypothyroidism (pvalue: 0.036) and prolactin 
disorders (pvalue:  0.058) in women of Recurrent Pregnancy Loss 
group.  
2 out of 3 patients with hyperprolactinemia had associated 
hypothyroidism, this was also observed by Van Gaal et al, where 
decrease in thyroid levels stimulates lactotrophs resulting in 
hyperprolactinemia. 
89 patients of primary and 11 patients of secondary miscarriage 
were included.19 antenatal patients were included, of which13 delivered 
term, 4 preterm, one intra uterine death, and one patient had recurrent 
miscarriage.   
 The other correlation was between the Body Mass Index and the 
number of abortion which has got a statistical significance of (0.010). 
This was also implicated in the study performed by 
 Metwally M et al 48, in women with Body Mass Index of more than 25; 
there exists increased cha1nces of spontaneous abortion(OR – 1.67). 
 Hamiton Fairley et al, 72 observed an increased miscarriage 
when Body Mass Index is increased when compared to normal.  
(60% vs 27%, pvalue < 0.05). 
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SUMMARY 
About 100 patients with previous history of 2 or more miscarriage 
who reported to Kilpauk Medical College and who fulfilled the 
inclusion and exclusion criteria were included in the study 
In recurrent miscarriage group of my study,  
There was 19% incidence of hypothyroidism, of which 57.9% are 
distributed among women with previous 4 losses. 
 Diabetes has been reported in 5% of population in this group, of 
which 80% were in the age group more than 30. 
Menstrual disturbances were observed in 63.2% of hypothyroid 
patients, 80% of diabetic patients and in all patients who had 
hyperprolactinemia.   
In women with previous history of infertility, 42.1% had 
hypothyroidism and 20% had Diabetes. In women with family history of 
thyroid, 31.6% had hypothyroidism and 66.7% had hyperprolactinemia. 
In my study, there is no statistical significance between Diabetes 
and hyperprolactinemia with the occurrence of abortion. 
Age and Body mass Index has a significant association with 
recurrent miscarriage. 
86 
 
CONCLUSION 
Recurrent miscarriage is a distressing situation both to the patient 
and the investigator until and unless the cause is established. The 
evaluation of endocrinological causes has been simple, easy and cost 
effective for the general population. 
1) Women with endocrinological dysfunction, majority of them 
will have some form of menstrual abnormality which could be evaluated 
by a proper history 
2) Hypothyroidism has a significant association with recurrent 
miscarriage group, hence early routine screening, diagnosis, treatment of 
subclinical and overt forms has a better obstetrical outcome reducing the 
mental agony of the patient. 
3) Women with positive family history of thyroid abnormality 
along with hypothyroidism are those candidates who need thyroid 
antibody evaluation. Routine screening for all cases is not necessary. 
4) Though, Diabetes mellitus as such do not cause abortion, 
women with poor glycemic control and those with elevated fasting 
blood glucose level are still considered as risk factors. This group of 
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women also has an associated insulin resistance which influences their 
future outcome. 
   5) Thyroid function test is done before confirming the diagnosis 
of hyper prolactinemia, and initiation of thyroxine substitution would 
correct subtle abnormalities in prolactin levels. 
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PROFORMA 
Name:                                                                                     IP.No: 
Age:                                                                                         PH.No: 
Address: 
MENSTRUAL HISTORY: 
Age at Menarche:  
Cycles: Regular/Irregular: 
Duration:                                                                                  LMP: 
MARITAL HISTORY: 
Married for 
Consanguinity: 
OBSTETRIC HISTORY: 
 
 
PAST HISTORY: not a known diabetic/ hypertension/thyroid disorders. 
 
Family History:  
            Abortion 
            Infertility 
            Diabetes 
PERSONAL HISTORY: 
HUSBAND:  
Age: 
Occupation: 
Smoking/alcohol: 
MEDICAL HISTORY: 
 
GENERAL  EXAMINATION: 
Height    
Weight BMI Breast  
Thyroid  BP  
Pulse  Cvs/Rs: 
 
P/A: 
P/S: 
P/V: 
 
INVESTIGATIONS 
Hb% 
Urine Routine 
Blood sugar: 
S.urea: 
S.creatinine: 
Blood group: 
VDRL: 
HIV: 
HBsAg: 
Pelvic Ultrasonogram: 
 
SPECIFIC INVESTIGATIONS: 
Glucose Tolerance Test: 
 
Thyroid Stimulating Hormone: 
 
S.Prolactin: 
ABBREVATIONS USED IN MASTER CHART 
R         –   Regular cycles 
IR       –   Irregular cycles 
CM     –  consanguineous marriage 
NCM  –  Non consanguineous marriage 
G        –  Gravida 
P         –  para 
L         –  live birth 
A         –  Abortion 
FH/DM  –  Family history of Diabetes Mellitus 
FH/Thyroid  –  Family history of Thyroid 
BMI     –  Body Mass Index 
GTT     –  Glucose Tolerance Test 
FBS      –  Fasting Bloog Sugar 
TSH      – Thyroid Stimulating Hormone 
PCOS    –  Polycystic Ovarian Disease 
SLE      –  Systemic Lupus Erythematosus 
LAC     –  Lupus AntiCoagulant 
LN        –  Labour Naturale 
LSCS    –  Lower Segment Ceasarean Section 
IUD      –  Intrauterine Death 
AP Eclampsia  –  Antepartum Eclampsia 
 
MASTER  CHART 
Name Age IP No 
Menstrual  
History 
Marital  
History Infertility  Score 6-9wks 9-12wks 
FH/
DM 
FH/ 
THYROID BMI GTT TSH Prolactin Others 
              FBS 2HR 
Suganya 20 2486 R CM NO A3 2 1 0 0 19.3 92 120 3.4 14 PCOS 
Sasikala 20 2811 R CM YES A2 1 1 0 0 27.3 86 132 5 8 N 
Sivagami 20 7824 R NCM NO A2 0 2 0 0 27.3 82 114 3.8 18 N 
Revathy 21 6978 R NCM NO A3 1 2 0 1 21.3 96 112 3.2 9 N 
Rubini 22 9285 IR CM NO A3 0 3 1 0 27.8 85 124 3.9 14 PCOS 
vanitha  22 6394 IR NCM NO A2 2 0 0 0 23.6 90 125 2.8 16 N 
Gayathri 22 12749 R NCM NO A4 1 3 0 0 24.8 83 110 6.5 12 PCOS 
Sheela 22 9633 IR NCM NO A2 2 0 0 0 18.9 82 126 5.5 17 PCOS 
Pattu 22 9318 R NCM NO A2 0 2 0 0 22 78 125 3.9 8 N 
Pavithra 22 8649 R NCM NO A2 1 1 0 0 23.4 82 132 2.8 14 N 
 Manimegalai    22 8310 IR NCM NO A4 2 2 0 1 26.4 81 112 6.8 13 N 
Nirmala 23 4111 R CM NO A3 0 3 1 0 23.6 95 125 2.7 15 N 
Lakshmi 23 2096 R NCM NO A2 0 2 0 0 22.1 91 136 3.5 18 N 
Rasathi 23 6729 R NCM NO A2 2 0 1 0 22 92 128 3.6 6 N 
radhika 23 6295 IR NCM NO A3 1 2 0 0 24.1 86 132 2 16 N 
sathya 24 4148 IR CM YES A4 3 1 0 1 27.8 88 115 8.7 14 N 
Meena 24 5762 R CM NO A3 0 3 0 0 19.7 79 125 4.8 18 N 
Name Age IP No 
Menstrual  
History 
Marital  
History Infertility  Score 6-9wks 9-12wks 
FH/
DM 
FH/ 
THYROID BMI GTT TSH Prolactin Others 
FBS 2HR 
Shalini 24 3720 IR NCM YES A4 2 2 0 0 19.2 81 133 6.8 14 N 
Nethravathi 24 11365 R NCM NO A2 0 2 0 0 26.8 85 128 4.2 12 N 
Jeeva 24 6743 R NCM NO A2 1 1 0 0 21 82 138 3.5 18 N 
Menaga 24 6049 IR NCM NO A4 1 3 0 1 19.4 83 129 9.2 14 N 
Nirmaladevi 24 5461 R NCM NO A2 1 1 1 0 19.7 92 138 3.8 18 N 
Sathya 25 14390 IR NCM NO A3 2 1 0 0 27.2 91 125 3.5 12 N 
 Susheela 25 4739 R NCM NO A2 0 2 0 0 24.8 73 113 3.5 11 N 
Devi 25 2904 R NCM NO A2 0 2 0 0 23.2 84 136 3.8 14 N 
Umadevi 25 2098 R NCM NO A3 1 2 0 1 26.2 86 132 2.9 17 N 
Kumari 25 12081 R NCM NO A2 2 0 0 0 25.8 82 126 4.2 8 N 
Revathy 26 7810 R CM NO A3 0 3 0 0 19.4 75 119 3.6 12 N 
Jeyalakshmi 26 4710 R NCM NO A3 1 3 0 0 20.8 71 132 3.4 9 N 
Malar 26 11057 R NCM NO A2 1 1 1 0 25.4 86 128 2.8 11 N 
Sagayamary      26 8120 IR NCM YES A4 3 1 0 0 19.6 98 126 8.5 26 N 
Nirmala 27 2151 R NCM NO A4 1 3 1 0 28.6 94 119 6.7 11 N 
Priya 27 7218 R NCM NO A3 3 0 0 0 29.3 86 123 3.2 14 N 
Rekha 27 3711 R CM YES A4 3 1 0 0 28.4 84 138 35 12 N 
Valli 27 3011 IR NCM YES A4 1 3 0 0 29.5 72 133 3.1 9 PCOS 
Malliga 27 9483 IR NCM NO A3 2 1 0 0 21 128 238 2.6 14 N 
Name Age IP No 
Menstrual  
History 
Marital  
History Infertility  Score 6-9wks 9-12wks 
FH/
DM 
FH/ 
THYROID BMI GTT TSH Prolactin Others 
FBS 2HR 
Kamala 27 10241 R NCM NO A2 1 1 0 0 26.8 86 120 2.5 6 N 
Shenbegam 27 4127 R CM NO A4 2 2 0 0 25.2 81 125 2.9 15 N 
Mahalakshmi 27 9285 IR CM yes A3 1 2 0 0 23.4 88 108 10 12 N 
Anandhi 27 7924 R NCM NO A3 1 2 0 0 21.8 91 135 2.3 8 N 
Jaya 28 7010 IR NCM NO A5 3 2 0 0 24.2 92 138 6 15 N 
valarmathy 28 7111 IR NCM NO A4 2 2 0 0 27.8 75 125 3.6 9 PCOS 
Nirmala 28 3618 R NCM NO A2 0 2 0 0 20.8 78 124 2.6 16 N 
Kamali 28 5230 R NCM NO A3 2 1 0 0 22.6 94 108 3.2 13 N 
sumathi 28 6840 R NCM NO A5 2 3 0 0 20.5 72 114 12 14 N 
Nithya 28 3528 R NCM NO A2 1 1 0 0 26.3 68 126 3.2 18 PCOS 
Pownamal 28 4697 R NCM NO A4 2 2 0 0 19.2 70 135 2.6 11 N 
Devi 28 8446 IR NCM NO A4 2 2 0 1 21.2 88 122 5.2 10 N 
Janaki 28 11016 R CM NO A3 1 2 0 0 23.6 98 116 2.3 9 N 
Latha 28 10235 R NCM NO A2 0 2 1 0 23.3 89 103 2.6 12 N 
Neela 28 8341 R NCM NO A2 2 0 0 1 21.3 84 128 3.5 14 N 
Dhanalakshmi 28 8340 R NCM NO A5 1 4 0 0 28.9 91 138 3.6 12 N 
mythili 29 4309 R CM NO A4 0 4 0 0 25.2 92 124 6 17 N 
Maheshwari 29 8156 IR NCM YES A2 2 0 0 1 26.9 88 126 3.2 33 N 
Banumathy 29 9624 R NCM NO A3 0 3 0 1 23.8 85 124 3.5 13 N 
Name Age IP No 
Menstrual  
History 
Marital  
History Infertility  Score 6-9wks 9-12wks 
FH/
DM 
FH/ 
THYROID BMI GTT TSH Prolactin Others 
FBS 2HR 
Sudha 29 7924 IR CM NO A3 1 2 0 0 24.1 86 132 3.4 17 PCOS 
Kumudha 30 6910 R NCM NO A3 3 0 0 0 20.8 75 132 4 8 N 
Nagalakshmi 30 8502 R CM NO A4 2 2 0 0 29.6 72 120 3.5 12 N 
Savithri 30 7051 IR NCM YES A6 2 4 0 0 28.3 88 115 6.2 14 PCOS 
Rekha 30 12091 IR NCM NO A3 0 3 0 0 22 86 126 3.2 9 SLE 
Rajeshwari 30 6284 R CM NO A4 2 2 0 0 28.4 81 132 3.5 15 N 
vanitha  30 5983 R NCM NO A4 2 2 0 0 22.1 83 138 2.9 14 N 
Reshma 30 10947 IR NCM NO A4 2 2 1 0 22.6 94 106 3.5 16 N 
Jaya 31 7020 IR NCM NO A4 2 2 1 0 28.2 132 224 2.9 15 N 
Sangeetha 31 9371 IR NCM NO A2 2 0 0 0 25.6 158 242 3.2 9 N 
Bharathi 31 7205 R NCM NO A4 1 3 0 0 26.2 88 138 3.5 17 N 
Leelavathy 31 15293 IR NCM NO A4 1 3 0 1 25.8 84 132 3.6 14 N 
Kamatchi 32 6581 R NCM NO A4 0 4 0 0 25.2 91 108 3 13 N 
Uma 33 7639 IR NCM YES A5 2 3 0 1 27.8 91 132 6 26 N 
Sasikala 34 4238 R NCM NO A4 2 2 0 0 25.8 88 138 3.5 12 N 
Thilagavathy 34 10283 R NCM NO A4 2 2 0 0 28.6 91 116 3.1 16 N 
Hemalatha 35 6811 R NCM NO A6 3 3 0 0 30.2 138 253 2.9 7 N 
Rani 35 4323 R NCM NO A4 0 4 0 0 31.2 82 128 2.6 9 N 
Anjugam 36 1089 R CM NO A4 2 2 1 0 27.8 88 119 2.4 15 N 
Name Age IP No 
Menstrual  
History 
Marital  
History Infertility  Score 6-9wks 9-12wks 
FH/
DM 
FH/ 
THYROID BMI GTT TSH Prolactin Others 
FBS 2HR 
Rajathi 36 7493 R NCM NO A4 2 2 0 0 27.6 86 127 3.2 10 N 
Kanagavalli 38 13268 R NCM NO A5 2 3 0 0 28.8 89 128 3.4 14 N 
Revathy 24 3529 IR NCM YES P1L1A4 2 2 0 0 28.4 78 136 8.6 8 PCOS 
Priya 27 3611 IR NCM YES P1L1A4 2 2 0 0 24.1 95 132 3.6 13 N 
Rajeshwari 27 5092 R NCM NO P1L1A2 2 0 0 0 18.6 83 128 3.5 15 N 
Hemalatha 36 8212 R NCM YES P1L1A4 1 2 0 0 23.8 92 138 3.6 16 N 
Amaramma 32 8410 IR CM YES P1L1A3 2 1 0 0 25.6 95 121 3.9 16 PCOS 
 
  
 Name Age IP No 
Menstrual  
History 
Marital  
History Infertility  Score 6-9wks 9-12wks FH/DM 
FH/ 
THYROID BMI 
GTT 
2hr TSH Prolactin Others 
Suganya 19 13211 R NCM NO G3A2 1 1 1 0 19.7 120 2.2 34 PRETERM LN 
Kalpana 20 13204 IR CM NO G3A2 1 1 0 0 19.4 132 1.9 32 TERM ,LN 
Radhika 24 14410 R CM NO G4A3 1 2 0 1 23.4 126 3.4 33 
LAC +VE  
TERM LN 
Valli 24 2111 R NCM NO G4A3 2 1 0 0 26.4 113 2.1 36 PRETERM LN 
Anjali 26 6061 R NCM NO G3A2 1 1 0 0 28.3 136 2.1 33 TERM LSCS 
Saraswathy 26 5293 R CM NO G3A2 0 2 0 0 26.4 116 2 36 TERM LN 
Sathya 27 4111 IR NCM NO G4A3 2 1 0 0 27.8 127 2 33 TERM LN 
Karthika 28 8210 IR NCM NO G5A4 2 2 0 0 22.6 134 1.9 34 TERM LN 
Geetha 28 9205 R NCM NO G5A4 2 2 0 0 28.8 130 3 38 TERM LN 
Komala 28 6577 R NCM NO G3A2 0 2 0 0 22.1 129 1.6 33 TERM LSCS 
Hemavathy 30 4011 R NCM NO G10A9 4 5 0 0 22.6 122 2 33 TERM LSCS 
Chitra 31 5396 IR NCM NO G10A9 3 6 0 1 26.5 112 2.1 35 
ABORTED  
AT 6mA 
Alice  38 4261 IR CM YES G4A3 2 1 0 0 29.5 160 1.9 37 TERM LSCS 
Subedha 
begum 26 1039 R NCM NO G5P1L1A3 1 2 0 1 21.9 128 1.9 35 TERM LSCS 
Sasikala 27 14469 IR NCM NO G5P1L1A3 0 3 0 0 26.8 112 2.1 37 
AP ECLAMSIA   
IUD 
Girija 28 13627 R NCM YES G6P1L1A4 2 2 0 1 25.2 113 2.1 35 
LAC +VE  
TERM LN 
 shyamala 28 9838 R NCM NO G3P1L1A2 1 1 0 0 24 129 1.5 36 TERM  LN 
Mariammal 32 6396 R NCM NO G5P1L1A3 1 2 0 0 25.5 132 1.8 35 PRETERM LN 
Shyamala devi 33 3811 R CM NO G6P1L1A4 3 1 1 0 22.4 127 2 34 PRETERM LN  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 

